Taysha Gene Therapies Inc (TSHA) — Financial Flexibility Index
Taysha Gene Therapies Inc (TSHA) has a Financial Flexibility Index of -0.46x as of March 2026. Free cash flow of $-40.85 Million (operating CF $-40.88 Million minus capex $24.00K) represents 0% of total liabilities ($88.41 Million). Check TSHA strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Taysha Gene Therapies Inc Financial Flexibility Index (2019–2025)
Historical Financial Flexibility Index trend for Taysha Gene Therapies Inc across 7 annual periods. See Taysha Gene Therapies Inc working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Taysha Gene Therapies Inc (2019–2025)
Year-by-year free cash flow to debt coverage for Taysha Gene Therapies Inc. For the full company profile including market capitalisation, see TSHA market cap.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.96x | $-92.35 Million | $-93.09 Million | $96.38 Million | ▼ -5.3% |
| 2024 | -0.91x | $-80.85 Million | $-81.22 Million | $88.84 Million | ▼ -35.6% |
| 2023 | -0.67x | $-65.65 Million | $-73.02 Million | $97.79 Million | ▼ -32.4% |
| 2022 | -0.51x | $-63.52 Million | $-88.39 Million | $125.33 Million | ▲ +37.1% |
| 2021 | -0.81x | $-95.49 Million | $-117.04 Million | $118.57 Million | ▲ +71.8% |
| 2020 | -2.86x | $-21.65 Million | $-30.73 Million | $7.58 Million | ▼ -297.4% |
| 2019 | 1.45x | $217.00K | $135.00K | $150.00K | — |